Evidence map›Paper›PMID 31916416›Full record

ArticleESC heart failure2020

The social return on investment of a new approach to heart failure in the Spanish National Health System.

María Merino, Margarita Jiménez, Nicolás Manito, Emilio Casariego, Yoana Ivanova, Almudena González-Domínguez, Maite San Saturnino, Álvaro Hidalgo-Vega, Carles Blanch

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Impact ofFrontiers in public health · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

María MerinoDepartment of Health Outcomes Research, Instituto Max Weber, Madrid, Spain.
Margarita JiménezDepartment of Pharmacoeconomics and Market Access, Instituto Max Weber, Madrid, Spain.
Nicolás ManitoDepartment of Heart Failure and Transplant, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Emilio CasariegoDepartment of Internal Medicine, Complejo Hospitalario de Lugo, Lugo, Spain.
Yoana IvanovaDepartment of Pharmacoeconomics and Market Access, Instituto Max Weber, Madrid, Spain.
Almudena González-DomínguezDepartment of Pharmacoeconomics and Market Access, Instituto Max Weber, Madrid, Spain.
Maite San SaturninoPresident, CardioAlianza, Barcelona, Spain.
Álvaro Hidalgo-VegaEconomy and Health Research Seminar, Universidad de Castilla-La Mancha, Toledo, Spain.
Carles BlanchEarly Access & Health Economics, Novartis, Barcelona, Spain.
Pharmacoeconomics and Health Outcomes Research Iberia (Spain) · ESBarcelona Graduate School of Mathematics · ESBellvitge University Hospital · ESCentre Max Weber · FRNovartis (Spain) · ESServicio de Salud de Castilla La Mancha · ESUniversity Hospital Complex Of Vigo · ESWeber · ES

Funding

Novartis Farmacéutica, S.A.
6 · The paper itself

Abstract

aimsWe aim to agree on a set of proposals to improve the current management of heart failure (HF) within the Spanish National Health System (SNHS) and apply the social return on investment (SROI) method to measure the social impact that these proposals would generate. METHODS AND

resultsA multidisciplinary working team of 16 experts was set up, with representation from the main stakeholders regarding HF: medical specialists (cardiologists, internal medicine physicians, general practitioners, and geriatric physicians), nursing professionals, health management professionals, patients, and informal caregivers. This team established a set of proposals to improve the management of HF according to the main areas of HF care: emergency and hospitalization, primary care, cardiology, and internal medicine. A forecast-type SROI method, with a 1-year time frame, was applied to measure the social impact resulting from the implementation of these proposals. The required investment and social return were estimated and summarized into a ratio indicating how much social return could be generated for each euro invested. Intangible returns were included and quantified through financial proxies. The approach to improve the management of HF consisted of 28 proposals, including the implementation of a case management nurse network, standardization of operational protocols, psychological support, availability of echocardiography machines at emergency departments, stationary units and primary care, early specialist visits after hospital discharge, and cardiac rehabilitation units, among others. These proposals would benefit not only patients and their informal caregivers but also the SNHS. Regarding patients, proposals would increase their autonomy in everyday activities, decrease anxiety, increase psychological and physical well-being, improve pharmacological adherence and self-care, enhance understanding of the disease, delay disease progression, expedite medical assessment, and prevent the decrease in work productivity associated with HF management. Regarding informal caregivers, proposals would increase their quality of life; improve their social, economic, and emotional well-being; and reduce their care burden. The SNHS would benefit from shorter stays of HF patients at intensive care units and reduction of hospitalizations and admissions to emergency departments. The investment needed to implement these proposals would amount to €548m and yield a social return of €1932m, that is, €3.52 for each euro invested.

conclusionsThe current management of HF could be improved by a set of proposals that resulted in an overall positive social return, varying between areas of analysis. This may guide the allocation of healthcare resources and improve the quality of life of patients with HF.

Indexed as

CardiologyHeart FailureSelf CareAgedCost of IllnessDelivery of Health CareHospitalizationHumansQuality of LifeSocial ConditionsDisease managementHeart failureSocial return on investment (SROI)Spanish National Health System

Identifiers

PMID31916416
PMCPMC7083495
OpenAlexW3000565103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.